A number of the other safety and tolerability issues associated with the GLP-1 agonists either occurred in too few patients to see numerical differences in risk between semaglutide and placebo (such as acute pancreatitis) or are events that would likely require much longer follow-up to determine risk (such as medullary thyroid cancer)
Over several weeks, a Mail & Guardian investigation traced a rapidly growing, highly lucrative shadow market for products labelled as retatrutide
A new Medicare initiative may soon help make these medications more accessible
For semaglutide, the shelf life is closely linked to how the vial is stored
Diabetes-related cardiomyopathy: the sweet story of glucose overload from epidemiology to cellular pathways
Cao Y, Chen A, An SS, Ji RW, Davidson D, Llinas M